SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 2.72 |
| Enterprise Value ($M) | 8.96 |
| Book Value ($M) | 9.69 |
| Book Value / Share | 1.35 |
| Price / Book | 0.28 |
| NCAV ($M) | -4.10 |
| NCAV / Share | -0.57 |
| Price / NCAV | -0.66 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.26 |
| Return on Assets (ROA) | -0.20 |
| Return on Equity (ROE) | -0.39 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.31 |
| Current Ratio | 1.06 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 10.12 |
| Assets | 23.91 |
| Liabilities | 14.22 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Effect Of Dilutive Securities | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Davis Michael A / | 25.00 | 5.18 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| CUBT – Curative Biotechnology, Inc. | CURLF – Curaleaf Holdings, Inc. |
| CVSI – CV Sciences, Inc. | CYDY – CytoDyn Inc. |
| DBVTF – DBV Technologies S.A. |
Financial data and stock pages provided by
Fintel.io